Valuation Yuhan Corporation

Equities

End-of-day quote Korea S.E. Other stock markets 2024-09-10			5-day change	1st Jan Change
120,500.00 ^KRW	+0.50%		-16.84%	+75.15%

08-22	South Korean Shares Rise After BOK Rate Hold; Yuhan Gains on FDA Approval	MT
08-22	Yuhan Shares Jump 4% After US FDA Approves Anti-Cancer Drug for US Markets	MT

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	2,952,225	4,693,094	4,261,559	4,093,463	5,152,134	9,089,431	-	-
Change	-	58.97%	-9.2%	-3.94%	25.86%	76.42%	-	-
Enterprise Value (EV) ¹	2,626	4,368	3,950	3,870	5,056	9,019	8,822	8,636
Change	-	66.29%	-9.57%	-2.01%	30.65%	78.38%	-2.19%	-2.11%
P/E ratio	75.2x	25.5x	41.5x	40.7x	37.9x	60.2x	45.4x	39.3x
PBR	1.67x	2.5x	1.96x	1.91x	2.36x	4.34x	4.04x	3.75x
PEG	-	0x	-0.9x	-30.91x	1.1x	5.8x	1.4x	2.5x
Capitalization / Revenue	1.99x	2.9x	2.52x	2.31x	2.77x	4.4x	3.98x	3.72x
EV / Revenue	1.77x	2.7x	2.34x	2.18x	2.72x	4.36x	3.86x	3.54x
EV / EBITDA	36.9x	30.3x	39x	49x	49.8x	51.4x	37x	30.8x
EV / EBIT	210x	51.8x	81.3x	107x	89x	81.3x	47x	39.2x
EV / FCF	114x	-193x	74.7x	93.9x	-291x	83.3x	46.1x	32.7x
FCF Yield	0.88%	-0.52%	1.34%	1.07%	-0.34%	1.2%	2.17%	3.06%
Dividend per Share ³	329.1	1,728	362.8	381	400	417.7	425.8	425.9
Rate of return	0.85%	2.66%	0.64%	0.7%	0.58%	0.35%	0.35%	0.35%
EPS ³	517.1	2,542	1,357	1,339	1,815	2,002	2,656	3,067
Distribution rate	63.6%	68%	26.7%	28.4%	22%	20.9%	16%	13.9%
Net sales ¹	1,480	1,620	1,688	1,776	1,859	2,067	2,283	2,443
EBITDA ¹	71.19	144	101.3	79.05	101.4	175.4	238.4	280.8
EBIT ¹	12.54	84.26	48.6	36.03	56.78	111	187.8	220.3
Net income ¹	36.61	192.8	102.6	95.14	142.5	157.7	208.8	243.8
Net Debt ¹	-325.8	-325.6	-312	-223.4	-96	-70.33	-267.7	-453.7
Reference price ³	38,913.83	64,874.20	56,326.53	54,476.19	68,800.00	120,500.00	120,500.00	120,500.00
Nbr of stocks (in thousands)	75,773	72,231	75,593	75,139	74,979	75,000	-	-
Announcement Date	20-02-27	21-02-24	22-02-16	23-02-23	24-02-06	-	-	-

¹KRW in Million²KRW in Billions³KRW

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield (Y)	Capi. ($)
YUHAN CORPORATION	60.19x	4.36x	51.43x	+0.35%	6.77B
MERCK KGAA	24.77x	3.78x	13.37x	+1.35%	81.63B
KYOWA KIRIN CO. LTD.	24.74x	2.77x	11.74x	+1.82%	11.81B
SK BIOPHARMACEUTICALS CO., LTD.	114.26x	15.17x	82.99x	-.--%	6.07B
BETTA PHARMACEUTICALS CO., LTD.	32.12x	5.81x	18.03x	+0.70%	2.19B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	11.56x	-	-	+17.31%	1.96B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	29.87x	-	-	-	1.88B
SUPERNUS PHARMACEUTICALS, INC.	115.48x	-	-	-	1.85B
INDIVIOR PLC	9.96x	1.05x	3.71x	-.--%	1.27B
Average	46.99x	5.49x	30.21x	+3.08%	12.82B
Weighted average by Cap.	32.84x	4.35x	19.37x	+1.52%